RxDoctor Payments Data

Scott West, PA

Physician Assistant · Orem, UTNPI 1114399839

Payments from drug & device makers

$933in general payments, 2019–2025

Across 48 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$217
  • Astellas Pharma US Inc$182
  • Pfizer$93
  • Amgen$92
  • Boehringer Ingelheim$53
  • Bayer$33
  • plus $261 from 11 others

What the payments were for

  • Food & beverage$83489%
  • Education$9911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$933 in reported general payments places this provider in the 70th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$16,654
Medicare patients
33
Services billed
715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban30$39,561
TrulicityDulaglutide27$26,506
JanuviaSitagliptin Phosphate16$26,481
XareltoRivaroxaban35$23,035
OzempicSemaglutide15$22,213
MyrbetriqMirabegron18$20,251
Spiriva RespimatTiotropium Bromide12$12,666
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$12,525
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,274
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$7,022
Fluticasone-SalmeterolFluticasone Propion/Salmeterol43$5,797
Liothyronine Sodium121$4,107
SymbicortBudesonide/Formoterol Fumarate14$3,472
Omeprazole162$3,326
Atorvastatin Calcium244$3,079

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$93$39,56130 claims
Lilly USA, LLCTrulicity$17$26,50627 claims
MerckJanuvia$29$26,48116 claims
Johnson & JohnsonXarelto$29$23,03535 claims
Novo NordiskOzempic$18$22,21315 claims
Astellas Pharma US IncMyrbetriq$182$20,25118 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$53$19,68823 claims
AstraZenecaBreztri Aerosphere, Symbicort$32$11,74627 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Orem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →